中成药治疗乳腺增生症临床应用指南(2021年版)

2022-04-20 全国《中成药治疗乳腺增生症临床应用指南》课题组 中国中西医结合外科杂志

预康复管理是加速术后康复的重要内容和启动环节。胸外科手术前多模式预康复可提高患者的围术期功能状态,改善手术预后的临床意义已得到广泛认可。但胸外科预康复的具体实施流程与内容尚缺乏指导规范,临床应用中也存

中文标题:

中成药治疗乳腺增生症临床应用指南(2021年版)

发布日期:

2022-04-20

简要介绍:

乳腺增生症在中医上属于“乳癖”范畴。中成药疗效较为稳定,具有缓解疼痛、不良反应相对较小、应用与携带方便等优点。《中成药治疗乳腺增生症临床应用指南》小组遵照用推荐分级的评估、制定与评价(GRADE)方法,制定《中成药治疗乳腺增生症临床应用指南(2021年版)》,为合理应用中成药治疗乳腺增生症提供参考和指导。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中成药治疗乳腺增生症临床应用指南(2021年版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=42d6c1c002a23029, title=中成药治疗乳腺增生症临床应用指南(2021年版), enTitle=, guiderFrom=中国中西医结合外科杂志, authorId=0, author=, summary=预康复管理是加速术后康复的重要内容和启动环节。胸外科手术前多模式预康复可提高患者的围术期功能状态,改善手术预后的临床意义已得到广泛认可。但胸外科预康复的具体实施流程与内容尚缺乏指导规范,临床应用中也存, cover=https://img.medsci.cn/20220426/1650984520600_5579292.png, journalId=0, articlesId=null, associationId=2660, associationName=全国《中成药治疗乳腺增生症临床应用指南》课题组, associationIntro=全国《中成药治疗乳腺增生症临床应用指南》课题组, copyright=0, guiderPublishedTime=Wed Apr 20 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>乳腺增生症在中医上属于&ldquo;乳癖&rdquo;范畴。中成药疗效较为稳定,具有缓解疼痛、不良反应相对较小、应用与携带方便等优点。《中成药治疗乳腺增生症临床应用指南》小组遵照用推荐分级的评估、制定与评价(GRADE)方法,制定《中成药治疗乳腺增生症临床应用指南(2021年版)》,为合理应用中成药治疗乳腺增生症提供参考和指导。&nbsp;</p>, tagList=[TagDto(tagId=20833, tagName=乳腺增生)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=35974, appHits=135, showAppHits=0, pcHits=437, showPcHits=35838, likes=2, shares=34, comments=5, approvalStatus=1, publishedTime=Wed Apr 27 15:42:00 CST 2022, publishedTimeString=2022-04-20, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Apr 26 22:44:28 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 10:35:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中成药治疗乳腺增生症临床应用指南(2021年版).pdf)])
中成药治疗乳腺增生症临床应用指南(2021年版).pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2116285, encodeId=4053211628549, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Fri Feb 24 15:37:57 CST 2023, time=2023-02-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222713, encodeId=8f3e1222e13b9, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220526/05bdd408a9fc431292667f8949a95271/0a4e2264442e4ba982c4252e7e69ed9b.jpg, createdBy=e30d8181848, createdName=阿刚医师, createdTime=Fri May 27 06:08:42 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216511, encodeId=c334121651151, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:32 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215214, encodeId=69771215214b5, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Thu Apr 28 06:59:39 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215127, encodeId=29c5121512e94, content=正需要🌹🌹🌹, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c632179531, createdName=发如雪20085, createdTime=Wed Apr 27 21:13:30 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2023-02-24 ms1000000439125996 来自广东省

    参考学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2116285, encodeId=4053211628549, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Fri Feb 24 15:37:57 CST 2023, time=2023-02-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222713, encodeId=8f3e1222e13b9, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220526/05bdd408a9fc431292667f8949a95271/0a4e2264442e4ba982c4252e7e69ed9b.jpg, createdBy=e30d8181848, createdName=阿刚医师, createdTime=Fri May 27 06:08:42 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216511, encodeId=c334121651151, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:32 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215214, encodeId=69771215214b5, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Thu Apr 28 06:59:39 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215127, encodeId=29c5121512e94, content=正需要🌹🌹🌹, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c632179531, createdName=发如雪20085, createdTime=Wed Apr 27 21:13:30 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2022-05-27 阿刚医师

    学习了,谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2116285, encodeId=4053211628549, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Fri Feb 24 15:37:57 CST 2023, time=2023-02-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222713, encodeId=8f3e1222e13b9, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220526/05bdd408a9fc431292667f8949a95271/0a4e2264442e4ba982c4252e7e69ed9b.jpg, createdBy=e30d8181848, createdName=阿刚医师, createdTime=Fri May 27 06:08:42 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216511, encodeId=c334121651151, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:32 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215214, encodeId=69771215214b5, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Thu Apr 28 06:59:39 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215127, encodeId=29c5121512e94, content=正需要🌹🌹🌹, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c632179531, createdName=发如雪20085, createdTime=Wed Apr 27 21:13:30 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2116285, encodeId=4053211628549, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Fri Feb 24 15:37:57 CST 2023, time=2023-02-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222713, encodeId=8f3e1222e13b9, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220526/05bdd408a9fc431292667f8949a95271/0a4e2264442e4ba982c4252e7e69ed9b.jpg, createdBy=e30d8181848, createdName=阿刚医师, createdTime=Fri May 27 06:08:42 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216511, encodeId=c334121651151, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:32 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215214, encodeId=69771215214b5, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Thu Apr 28 06:59:39 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215127, encodeId=29c5121512e94, content=正需要🌹🌹🌹, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c632179531, createdName=发如雪20085, createdTime=Wed Apr 27 21:13:30 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2022-04-28 1064510_1039
  5. [GetPortalCommentsPageByObjectIdResponse(id=2116285, encodeId=4053211628549, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Fri Feb 24 15:37:57 CST 2023, time=2023-02-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1222713, encodeId=8f3e1222e13b9, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220526/05bdd408a9fc431292667f8949a95271/0a4e2264442e4ba982c4252e7e69ed9b.jpg, createdBy=e30d8181848, createdName=阿刚医师, createdTime=Fri May 27 06:08:42 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216511, encodeId=c334121651151, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:32 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215214, encodeId=69771215214b5, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Thu Apr 28 06:59:39 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215127, encodeId=29c5121512e94, content=正需要🌹🌹🌹, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c632179531, createdName=发如雪20085, createdTime=Wed Apr 27 21:13:30 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2022-04-27 发如雪20085

    正需要🌹🌹🌹

    0